OM
Opaleye Management’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-90,000
| Closed | -$2.43M | – | 44 |
|
2022
Q2 | $2.43M | Sell |
90,000
-105,500
| -54% | -$2.84M | 1.09% | 24 |
|
2022
Q1 | $6.66M | Sell |
195,500
-648,500
| -77% | -$22.1M | 2.07% | 17 |
|
2021
Q4 | $32.6M | Sell |
844,000
-141,000
| -14% | -$5.45M | 6.92% | 4 |
|
2021
Q3 | $53M | Hold |
985,000
| – | – | 9.91% | 2 |
|
2021
Q2 | $32.9M | Hold |
985,000
| – | – | 5.47% | 3 |
|
2021
Q1 | $20.3M | Sell |
985,000
-7,000
| -0.7% | -$144K | 2.98% | 10 |
|
2020
Q4 | $17.4M | Hold |
992,000
| – | – | 2.27% | 15 |
|
2020
Q3 | $14.7M | Sell |
992,000
-79,000
| -7% | -$1.17M | 2.88% | 12 |
|
2020
Q2 | $13.9M | Buy |
+1,071,000
| New | +$13.9M | 2.81% | 13 |
|